The GTPBP3 gene helps mitochondria, the parts of cells that make energy, build proteins correctly. The protein made by this gene helps your cells keep energy production steady, especially in tissues that need a lot of energy, like the brain, muscles, and heart. If both copies do not work properly, a person may develop a mitochondrial condition with developmental delay, low muscle tone, feeding problems, seizures, or heart muscle disease. Symptoms can vary widely from one person to another.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes contain the directions for making proteins, which are the working parts of cells. Other genes mainly help direct when certain processes take place, where they occur, and how strongly they run. Together, genes affect how the body develops and functions, and they can shape how you respond to food, stress, or medications. For a more in depth look at this topic, you can learn more in LearnHub.
Overview
GTPBP3Gene function
What if the gene works
The GTPBP3 gene helps mitochondria, the parts of cells that make energy, build proteins correctly. This supports steady energy production, especially in tissues with high energy needs such as the brain, muscles, and heart.
Risk
What if the gene does not work
Pathogenic variants in the GTPBP3 gene can cause a mitochondrial condition that often affects the heart and brain. Features may include lactic acidosis, developmental delay, and heart muscle disease, with milder to more severe variants influencing onset and severity.
Treatment
What does that mean for your treatment
No GTPBP3-specific treatment or drug selection approach is currently established in clinical guidelines. The GTPBP3 gene is being studied in mitochondrial disease research because its pathway affects how mitochondria make energy, but this has not yet led to a gene directed therapy.
Conditions associated with GTPBP3
Gene function
What if the gene works
Your cells need the GTPBP3 gene for steady energy production, especially in mitochondria, the parts of cells that make usable energy. It helps prepare certain transfer RNAs, small helper molecules used to build proteins. When this process runs smoothly, mitochondria can read their own instructions and make energy related proteins more reliably.
Inside mitochondria, the GTPBP3 gene helps add a small chemical tag to certain transfer RNAs, the helper molecules used during protein building. This tag helps those RNAs work in a stable, efficient way.
These tagged transfer RNAs help mitochondria read genetic instructions more accurately when making proteins. That supports smoother protein assembly and helps the cell avoid mix ups during this step.
Many proteins made with help from the GTPBP3 gene are part of the cell’s energy system inside mitochondria. When this gene is working normally, your mitochondria can make energy in a steady everyday way.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These changes are common and help explain normal differences among people, such as appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GTPBP3 gene can make its mitochondrial protein less stable or less active, so mitochondria may modify transfer RNAs less effectively and assemble energy-making proteins less reliably. In looking at how variants in the GTPBP3 gene affect protein function, milder changes may leave some activity, while more severe loss-of-function variants can remove most or all activity. This range in effect can lower cellular energy production to different degrees and, in affected people, may influence how early symptoms appear and how broad they are.
How variants are linked to conditions
Pathogenic variants in the GTPBP3 gene can cause a rare inherited mitochondrial condition called combined oxidative phosphorylation deficiency 23. GTPBP3-related mitochondrial disease usually starts in infancy or childhood and is linked to developmental delay, low muscle tone, lactic acidosis, seizures, and heart muscle disease, especially hypertrophic cardiomyopathy. A person typically needs pathogenic variants in both copies of the gene for the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely found in the general population. Most do not directly affect health and instead are part of natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definitive diagnosis, particularly when multiple genes and environmental factors are involved. In other cases, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the GTPBP3 gene. For many living with a disease-causing change in GTPBP3, risk is mainly shaped by the genetic change itself rather than lifestyle, so care usually focuses on monitoring and treating health problems early.
Inheritance of GTPBP3 variants
Variants in the GTPBP3 gene are inherited in an autosomal recessive pattern. This means a person usually inherits one changed copy from each parent, and both parents are typically healthy carriers. When both parents carry a variant in the GTPBP3 gene, each pregnancy has a 25% chance of the child inheriting both changed copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. In practical terms, how variants of the GTPBP3 gene are inherited usually becomes clear when the same condition appears only when both gene copies are affected.
What does my GTPBP3 result mean for my family?
Changes in GTPBP3 are linked to a rare inherited condition that usually runs in families in a recessive pattern. For family members, this often means parents may be healthy carriers, brothers and sisters could also be affected or be carriers, and other relatives may carry the same change. The meaning for each relative depends on whether they inherited the gene change from one or both parents.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the GTPBP3 gene, a genetic test for GTPBP3 variants reads DNA from a blood, saliva, or cheek swab sample. The lab looks for changes in the gene and reports whether it found a known disease causing variant, no relevant variant, or a variant of uncertain significance (a change whose meaning is not yet clear).
When should I consider getting a genetic test?
Genetic testing for the GTPBP3 gene may be worth considering when a baby or child has signs of a rare inherited energy condition, such as heart muscle disease, developmental delay, low muscle tone, or repeated lactic acidosis. It can also help when there is a family history of the same condition.
A genetic result is only one part of your health story
A genetic finding can provide useful information, but how much clarity it offers depends on the condition and the specific type of variant. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information adds context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This is common and helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences can affect the way a person responds to medications. It studies gene drug patterns to help explain why the same treatment may work differently in different people. For many medicines, genes can influence how powerfully a drug works or how the body handles it. This information can support treatment choices that are more informed and more tailored to the individual. To look into this subject more closely, you can read more in the LearnHub.
Drugs influenced by the GTPBP3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so any concerns about side effects, unexpected reactions, or treatment choices are best discussed with your doctor or pharmacist.
History
In the early 2000s, researchers identified the GTPBP3 gene as part of the machinery that helps mitochondria, the cell’s energy centers, work properly. From these first observations, research expanded steadily. Scientists later linked harmful variants in the GTPBP3 gene to a rare inherited mitochondrial condition, which helped explain why some affected children developed problems such as high lactic acid levels, weak muscle tone, or heart involvement. As genetic testing became more widely used, doctors recognized that the condition can look different from one person to another. Over time, the GTPBP3 gene moved from being a gene of basic biological interest to one with a clear place in mitochondrial medicine.